STAAR Surgical Company (STAA)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 76.32% | 78.73% | 79.24% | 78.51% | 78.36% | 77.92% | 77.97% | 78.61% | 78.55% | 78.25% | 77.75% | 77.70% | 77.51% | 77.23% | 76.39% | 74.15% | 72.41% | 72.20% | 72.19% | 73.65% |
| Operating profit margin | -4.02% | 7.53% | 7.90% | 7.05% | 8.71% | 6.01% | 8.52% | 11.70% | 15.40% | 17.98% | 16.95% | 15.64% | 14.47% | 13.81% | 13.13% | 8.59% | 4.14% | 3.22% | 2.35% | 5.99% |
| Pretax margin | 6.77% | 10.26% | 8.59% | 8.20% | 10.45% | 8.36% | 10.38% | 13.15% | 16.02% | 16.66% | 15.80% | 15.06% | 13.58% | 13.39% | 13.16% | 8.82% | 5.06% | 4.13% | 2.84% | 6.47% |
| Net profit margin | 4.46% | 6.38% | 4.99% | 4.69% | 6.62% | 6.27% | 8.14% | 10.81% | 13.63% | 13.54% | 12.83% | 11.98% | 10.63% | 10.53% | 10.08% | 6.17% | 3.62% | 5.73% | 5.03% | 8.21% |
STAAR Surgical Company's profitability ratios show a positive trend over the past few years. The Gross profit margin has generally been increasing from 73.65% in March 2020 to 76.32% in December 2024, indicating effective cost management and pricing strategies.
The Operating profit margin also demonstrates improvement, with fluctuations along the way. It rose from 5.99% in March 2020 to a peak of 17.98% in September 2022, before declining to 7.53% in September 2024. This suggests fluctuations in operating expenses and efficiency in generating profits from operations.
The Pretax margin displays a similar pattern of growth, reaching a peak of 16.66% in September 2022. However, there were some fluctuations in between, with a slight decline to 6.77% by December 2024. This indicates the company's ability to control expenses and generate profits before taxes.
The Net profit margin, which reflects overall profitability after all expenses including taxes, also shows a positive trajectory. It increased from 8.21% in March 2020 to 13.63% in December 2022. However, there was a notable decrease to 4.46% by December 2024, possibly indicating challenges in sustaining profitability.
Overall, STAAR Surgical Company has shown improvement in its profitability ratios over the years, although there have been fluctuations in certain periods that may require further investigation. Monitoring these ratios can provide insights into the company's operational efficiency and financial health.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -2,472.75% | 4.78% | 5.13% | 4.67% | 5.75% | 3.96% | 5.92% | 8.23% | 10.46% | 12.72% | 11.80% | 10.82% | 9.64% | 9.25% | 9.20% | 5.78% | 2.63% | 2.14% | 1.60% | 4.43% |
| Return on assets (ROA) | 2,742.35% | 4.05% | 3.24% | 3.11% | 4.37% | 4.12% | 5.65% | 7.61% | 9.25% | 9.58% | 8.93% | 8.29% | 7.09% | 7.06% | 7.06% | 4.15% | 2.30% | 3.82% | 3.42% | 6.07% |
| Return on total capital | -3,176.57% | 6.00% | 6.10% | 5.13% | 6.24% | 3.95% | 6.72% | 9.63% | 12.82% | 15.24% | 14.34% | 13.60% | 12.74% | 12.06% | 11.54% | 7.18% | 3.35% | 2.62% | 1.91% | 4.99% |
| Return on equity (ROE) | 3,522.92% | 5.09% | 4.06% | 3.89% | 5.53% | 5.14% | 7.04% | 9.40% | 11.53% | 11.82% | 11.22% | 10.54% | 9.48% | 9.20% | 8.86% | 5.15% | 3.00% | 4.81% | 4.27% | 7.61% |
STAAR Surgical Company's profitability ratios reflect a mixed performance over the analyzed period.
1. Operating return on assets (Operating ROA) increased consistently from March 31, 2022, to September 30, 2022, peaking at 12.72%. However, there was a notable decline by December 31, 2022, and a significant drop to -2,472.75% by December 31, 2024, indicating a drastic decrease in profitability.
2. Return on assets (ROA) showed a similar trend, with a peak of 9.58% on September 30, 2022, before decreasing steadily to 4.05% by September 30, 2024. Notably, there was a spike to 2,742.35% on December 31, 2024, which may indicate unusual financial events.
3. Return on total capital experienced a consistent upward trend from March 31, 2020, to September 30, 2022, reaching a peak of 15.24%. However, the ratio dropped sharply by December 31, 2022, and plunged to -3,176.57% by December 31, 2024, reflecting significant challenges in utilizing capital effectively.
4. Return on equity (ROE) performance also displayed fluctuations, with a peak of 11.82% on September 30, 2022. Subsequently, the ratio decreased to 5.09% by September 30, 2024. The ROE ratio saw substantial volatility, with a remarkable spike to 3,522.92% by December 31, 2024, indicating potential anomalies in equity returns.
In conclusion, while STAAR Surgical Company showed periods of profitability growth, the significant fluctuations and extreme ratios recorded raise concerns about the company's financial stability and operational efficiency. Further analysis and contextual information would be crucial to understand the underlying reasons behind these fluctuations.